📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-07 18:13
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
13 announcements match the current filters (relevance ≥ 5).
Kanoria Chem Launches 12 TPD Triacetin Facility at Ankleshwar
Kanoria Chemicals & Industries has launched a new 12 Metric Tons per Day (TPD) Triacetin manufacturing facility at its existing manufacturing site in GIDC, Ankleshwar, Gujarat. The facility is operational as of October 7, 2026, targeting domestic and export markets across food, pharma, agrochemicals, and plastics. This product addition expands the company's specialty chemicals portfolio alongside existing products like Pentaerythritol, Formaldehyde, and Hexamine. While the specific capex investment was not disclosed, the addition represents an incremental capacity buildout (~4,380 TPA potential) supporting higher-value specialty product volume.
Confidence: HIGH
What changedKanoria Chemicals officially commissioned a new 12 TPD manufacturing plant for Triacetin at its Ankleshwar site.
Why it mattersEnhances the company's specialty chemicals mix into higher-margin end markets (food and pharma), complementing its existing bulk alcohol-based intermediates.
Capacity added: 12 Metric Tons per Day (TPD)Launch date: 07.10.2026Capex spend: not disclosed
📅 Short termSentiment will be modestly positive as the facility is already operational and adds to product diversification without prolonged construction delays.
📈 Long termExpands value-added specialty chemical offerings, supporting management's Vision-2030 roadmap and potentially improving blended chemical segment operating margins.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Capex and expected revenue contribution are not disclosed
- Market absorption and pricing realization risks in global and domestic specialty chemical markets
Key Highlights
Commissioned new Triacetin plant with a capacity of 12 Metric Tons per Day (TPD)
Facility launched at the existing manufacturing site in GIDC, Ankleshwar, Gujarat on October 7, 2026
Product targets both domestic and international markets across chemical, food, and pharma segments
Capex outlay and expected revenue generation from the facility were not disclosed
👀 What to Watch
Monitor upcoming quarterly disclosures for capacity ramp-up, utilization rates, and margin contribution from the new Triacetin line relative to chemical segment run-rates.
₹460 Cr Revenue: Kanoria Chemicals Reports 128% YoY Growth and Turnaround in Q1 FY27
Kanoria Chemicals delivered a strong Q1 FY27 performance with consolidated revenue jumping 128% YoY to ₹460.37 cr, compared to ₹201.38 cr in the year-ago period. The company turned profitable with a consolidated PAT of ₹26.36 cr, reversing a loss of ₹13.78 cr in Q1 FY26. Growth was primarily driven by the Chemical segment, which saw revenue surge 130% to ₹429.99 cr. Additionally, the company issued ₹49.50 cr in preference shares on April 1, 2026, resulting in a one-time fair valuation gain of ₹6.30 cr in other income.
Confidence: HIGH
What changedThe company has moved from a period of significant losses to strong profitability, supported by a massive jump in chemical sales and the deconsolidation of APAG Holding AG as a subsidiary.
Why it mattersThe sharp revenue growth (Q1 revenue is ~37% of TTM revenue) suggests that recent capacity expansions in Formaldehyde and Hexamine are scaling effectively, significantly improving the company's cash flow profile.
Consolidated Revenue (Q1 FY27): ₹460.37 crChemical Segment Revenue: ₹429.99 crConsolidated PAT: ₹26.36 crPreference Share Issuance: ₹49.50 crQ1 Revenue vs TTM Revenue: 37.3%
📅 Short termThe stock is likely to react positively to the sharp turnaround in profitability and the substantial YoY revenue growth exceeding previous quarterly averages.
📈 Long termStructural improvement is evident as the company leverages anti-dumping duties and new capacities; however, long-term value depends on managing methanol price volatility and Ethiopian currency risks.
⚠ Risk flags
- High client concentration (top 10 customers contribute 44% of income)
- Sensitivity to Methanol price spikes
- Foreign currency shortage risks in Ethiopian textile operations
Key Highlights
Consolidated revenue from operations grew 128.6% YoY to ₹460.37 cr from ₹201.38 cr.
Chemical segment revenue increased to ₹429.99 cr, representing 93.4% of total consolidated revenue.
Turned around to a consolidated profit of ₹26.36 cr from a loss of ₹13.78 cr in the same quarter last year.
Issued 4,95,000 Non-Convertible Redeemable Preference Shares (NCRPS) at ₹1,000 each, totaling ₹49.50 cr.
Recorded a fair valuation gain of ₹6.30 cr in other income related to the preference share issuance.
👀 What to Watch
Investors should monitor the sustainability of the Chemical segment's margins and the volume ramp-up of the new Ankleshwar plant, as well as the recovery progress in the Textile segment which reported a modest profit of ₹2.59 cr.
Kanoria Chemicals Approves FY26 Audited Results; Skips Dividend for FY 2025-26
Kanoria Chemicals & Industries Limited's Board has approved the audited financial results for the quarter and year ended March 31, 2026. Notably, the company has decided not to recommend any dividend for the financial year 2025-26. The Board also approved the re-appointment of Smt. Suhana Murshed as an Independent Director for a second five-year term. The statutory auditors provided an unmodified opinion, confirming the reliability of the financial disclosures.
Key Highlights
Approved audited standalone and consolidated financial results for the year ended March 31, 2026.
The Board recommended no dividend for the financial year 2025-26.
Re-appointed Smt. Suhana Murshed as an Independent Director for a second 5-year term starting June 29, 2026.
Statutory auditors Singhi & Co. issued an audit report with an unmodified opinion on the financial results.
👀 What to Watch
Investors should examine the full financial statement to understand the rationale for skipping the dividend. Monitor the company's cash flow and profitability trends for the upcoming fiscal year.
Kanoria Chemicals FY26 Results: Board Recommends No Dividend, Re-appoints Independent Director
Kanoria Chemicals & Industries Limited has approved its audited financial results for the fiscal year ended March 31, 2026. The Board of Directors has notably recommended no dividend for the financial year 2025-26, which may be viewed cautiously by income-focused investors. Governance remains stable with the re-appointment of Smt. Suhana Murshed as an Independent Director for a second five-year term. Additionally, the company has re-appointed its internal and cost auditors for the upcoming 2026-27 fiscal year.
Key Highlights
Audited standalone and consolidated financial results for FY26 approved with an unmodified audit opinion.
Board recommended no dividend payment for the financial year ended March 31, 2026.
Smt. Suhana Murshed re-appointed as Independent Director for a second 5-year term effective June 29, 2026.
Internal and Cost Auditors re-appointed for the financial year 2026-27 to ensure audit continuity.
👀 What to Watch
Investors should examine the detailed profit and loss statements to identify the reasons behind the skipped dividend. Maintain a watch on the company's cash flow management and operational margins in the chemical sector.
Kanoria Chemicals Allots Rs 49.50 Crore Preference Shares to Promoter Group
Kanoria Chemicals & Industries Limited has allotted 4,95,000 unlisted preference shares to R.V. Investment and Dealers Limited, a member of the promoter group. The allotment, valued at Rs 49.50 Crores, consists of 7% Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares at a face value of Rs 1,000 each. This capital infusion by the promoters demonstrates financial support and confidence in the company's long-term prospects. The allotment was finalized on April 20, 2026, and disclosed under insider trading regulations.
Key Highlights
Allotment of 4,95,000 unlisted preference shares to promoter group entity R.V. Investment and Dealers Limited
Total capital infusion amounting to Rs 49.50 Crores at Rs 1,000 per share
Instruments are 7% Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares
Promoter group entity already holds a 7.35% equity stake in the company
Allotment completed on April 20, 2026, strengthening the company's capital base
👀 What to Watch
Investors should view this promoter-led capital infusion as a sign of confidence in the company's stability. Monitor the company's upcoming financial results to see how this liquidity is utilized for debt reduction or expansion.
Kanoria Chemicals Allots 7% Preference Shares Worth Rs 49.5 Crore to Promoter Group
Kanoria Chemicals & Industries Limited has approved the allotment of 4,95,000 Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS). These shares, with a face value of Rs 1,000 each, were issued to R. V. Investment and Dealers Limited, a promoter group entity. The preferential allotment on a private placement basis has raised an aggregate consideration of Rs 49.5 crore. This capital infusion by the promoter group indicates strong internal support and provides the company with additional liquidity.
Key Highlights
Allotment of 4,95,000 NCRPS at a face value of Rs 1,000 per share
Total capital raised amounts to Rs 49.5 crore through private placement
The preference shares carry a 7% dividend rate and are non-convertible
The entire issue was subscribed by a single promoter group entity
👀 What to Watch
Investors should view this promoter-led capital infusion as a sign of confidence in the company's long-term prospects. Monitor the company's upcoming quarterly results to see how this liquidity improves the balance sheet or funds growth initiatives.
Kanoria Chemicals Board Approves Letter of Offer for NCRPS Issuance
The Board of Directors of Kanoria Chemicals & Industries Limited has approved the Letter of Offer (PAS-4) for the issuance of Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS). This follows the prior approval granted by shareholders during the Extra-Ordinary General Meeting held on April 1, 2026. The move indicates a structured approach to capital raising, although specific financial details such as the total issue size or coupon rate were not disclosed in this specific filing. This procedural step moves the company closer to finalizing the private placement or offer of these preference shares.
Key Highlights
Board approved the Letter of Offer (Form PAS-4) for NCRPS on April 13, 2026.
The issuance follows shareholder approval from the Extra-Ordinary General Meeting held on April 1, 2026.
The instruments are Non-Convertible, Non-Cumulative, Non-Participating, and Redeemable Preference Shares.
The board meeting was conducted efficiently, lasting 20 minutes from 11:00 AM to 11:20 AM.
👀 What to Watch
Investors should monitor subsequent filings for the specific issue size and dividend rate of the NCRPS to evaluate the impact on the company's cost of capital. While preference shares do not dilute equity, they do create a fixed dividend obligation that precedes common equity holders.
Kanoria Chemicals Shareholders Approve Capital Increase and Preference Share Issuance
Kanoria Chemicals & Industries Limited held an Extraordinary General Meeting (EGM) on April 1, 2026, where shareholders approved two significant special resolutions. The first resolution involves an increase in the company's Authorised Share Capital and a corresponding amendment to the Memorandum of Association. The second resolution approves the private placement of Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS) at a face value of ₹1,000 each to M/s. R. V. Investment and Dealers Limited. Both resolutions were passed with nearly 100% of the valid votes in favor, indicating strong shareholder support for the company's capital-raising plans.
Key Highlights
Shareholders approved the increase in Authorised Share Capital via a special resolution with 3,20,78,940 votes in favor.
Approval granted for the issuance of Redeemable Preference Shares (NCRPS) of ₹1,000 each on a private placement basis.
The resolution for NCRPS issuance received 2,88,68,820 votes in favor, representing 100% of valid votes cast on that item.
The EGM was attended by 63 shareholders through video conferencing, including 6 from the promoter group.
All proposed resolutions were passed with the requisite majority as per the Scrutinizer's report dated April 2, 2026.
👀 What to Watch
Investors should view the successful passing of these resolutions as a positive step toward strengthening the company's capital base. Monitor the specific terms of the NCRPS and how the management intends to deploy the newly raised capital for growth or debt management.
Kanoria Chemicals Approves Capital Increase and Preference Share Issuance at EGM
Kanoria Chemicals & Industries Limited held an Extraordinary General Meeting (EGM) on April 1, 2026, to approve key financial restructuring measures. Shareholders deliberated on increasing the company's Authorized Share Capital and the issuance of Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS). These preference shares, with a face value of Rs. 1,000 each, are slated for allotment to M/s. R. V. Investment and Dealers Limited on a private placement basis. The meeting saw participation from 63 members representing approximately 3.21 crore equity shares.
Key Highlights
Proposed increase in Authorized Share Capital and consequent amendment to the Memorandum of Association.
Issuance of Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS) at Rs. 1,000 per share.
Private placement of NCRPS to be allotted to M/s. R. V. Investment and Dealers Limited.
63 members representing 3,20,76,136 equity shares participated in the EGM via video conferencing.
The e-voting results and Scrutinizer's Report are pending and will be submitted to the exchanges separately.
👀 What to Watch
Investors should monitor the upcoming disclosure of the final voting results and specific terms of the NCRPS, such as the dividend rate and redemption timeline, to assess the impact on the company's capital structure.
Kanoria Chemicals to Raise ₹50 Crore via Preference Shares; EGM Set for April 1, 2026
Kanoria Chemicals & Industries Limited has called an Extraordinary General Meeting (EGM) on April 1, 2026, to seek approval for a ₹50 crore fundraise. The company proposes to issue 5,00,000 Non-Convertible Redeemable Preference Shares (NCRPS) at ₹1,000 each to M/s. R. V. Investment and Dealers Limited. To accommodate this, the company is also seeking to double its Authorized Share Capital from ₹50 crore to ₹100 crore. The preference shares will carry a 7% annual coupon and are redeemable over a period of 8 to 12 years.
Key Highlights
Proposed increase in Authorized Share Capital from ₹50 crore to ₹100 crore.
Issuance of 5,00,000 NCRPS aggregating to ₹50 crore on a private placement basis.
Fixed dividend rate of 7% per annum on a non-cumulative basis.
Redemption scheduled in five equal installments between the 8th and 12th year from allotment.
The NCRPS will be non-convertible and will not be listed on any stock exchange.
👀 What to Watch
Investors should note that this fundraise is via non-convertible preference shares, meaning there is no immediate equity dilution. Monitor the company's subsequent disclosures regarding the specific use of these funds for growth or debt refinancing.
Kanoria Chemicals Q3 Results: Turnaround to Profit of ₹3.55 Cr; Revenue Up 47% YoY
Kanoria Chemicals & Industries reported a significant turnaround in Q3 FY26, posting a consolidated net profit of ₹3.55 crore compared to a net loss of ₹28.63 crore in the same period last year. Consolidated revenue from operations grew by 47.4% YoY to ₹265.82 crore, driven primarily by the Alco Chemicals segment. The company's bottom line for the nine-month period was significantly boosted by a one-time gain of ₹97.66 crore following the loss of control of its subsidiary, APAG Holding AG. Despite an impairment of ₹10.64 crore on investments, the core chemical business showed improved operational resilience.
Key Highlights
Consolidated Revenue from operations increased to ₹265.82 crore in Q3 FY26 from ₹180.35 crore in Q3 FY25.
Reported a Consolidated Net Profit of ₹3.55 crore for the quarter, reversing a loss of ₹28.63 crore YoY.
Alco Chemicals segment revenue grew to ₹230.58 crore, while the Textile segment contributed ₹35.24 crore.
Recognized a substantial gain of ₹97.66 crore in the nine-month period due to the loss of control of APAG Holding AG.
Standalone EBITDA stood at ₹16.03 crore for the quarter, up from ₹12.46 crore in the previous year's corresponding quarter.
👀 What to Watch
The shift from losses to profitability and robust revenue growth in the core chemical segment are encouraging signs for shareholders. Investors should monitor the sustainability of these margins and the impact of the APAG subsidiary divestment on future consolidated earnings.
Kanoria Chemicals Q3 Turnaround: Reports ₹3.55 Cr Profit as Revenue Jumps 47% YoY
Kanoria Chemicals & Industries Limited reported a significant turnaround in Q3 FY26, posting a consolidated net profit of ₹3.55 crore compared to a net loss of ₹28.63 crore in the same period last year. Consolidated revenue from operations grew by 47.4% YoY to ₹265.82 crore, driven by strong growth in both the Alco Chemicals and Textile segments. The company's financial profile has improved following the loss of control of its subsidiary APAG Holding AG, which was previously a drag on consolidated performance. Standalone results also showed a return to profitability with a PAT of ₹3.93 crore.
Key Highlights
Consolidated Revenue from Operations increased 47.4% YoY to ₹265.82 crore in Q3 FY26.
Turned profitable with a Consolidated PAT of ₹3.55 crore versus a loss of ₹28.63 crore in Q3 FY25.
Alco Chemicals segment revenue grew 42% YoY to ₹230.58 crore, contributing the bulk of the top line.
Textile segment revenue nearly doubled to ₹35.24 crore with a segment profit of ₹3.14 crore.
Standalone 9-month profit stands at ₹5.76 crore compared to a loss of ₹18.51 crore in the previous year's 9-month period.
👀 What to Watch
The turnaround to profitability and strong revenue growth across all segments are positive indicators; investors should monitor if the company can maintain these margins without the drag of discontinued operations.
Supreme Court Dismisses Income Tax Department's Appeal Against Kanoria Chemicals
The Supreme Court of India has dismissed a long-standing civil appeal (No. 13772/2015) filed by the Commissioner of Income Tax (CIT-IV Kolkata) against Kanoria Chemicals & Industries Limited. The dismissal follows a legal precedent set in the Jindal Steel & Power case, which ruled against the revenue department on similar grounds. This resolution concludes a litigation process that has been pending since 2015, providing finality to the tax matter. While the company states there is no material impact on current operations, the ruling removes a potential contingent liability.
Key Highlights
Supreme Court dismissed Civil Appeal No. 13772/2015 filed by CIT-IV Kolkata on January 28, 2026.
The ruling was based on the precedent set in the CIT v. Jindal Steel & Power Limited case decided in December 2023.
The litigation had been ongoing for over a decade, with the original appeal dating back to 2015.
Company confirmed that the dismissal of the appeal has no material impact on its current financial operations.
The disclosure was made voluntarily under Regulation 30 of SEBI (LODR) Regulations to maintain transparency.
👀 What to Watch
Investors should view this as a positive development as it eliminates a long-standing legal overhang and potential tax liability. No further action is required as the company confirms no material impact on current financials.
